VTGN
VistaGen Therapeutics Inc
Price:  
2.11 
USD
Volume:  
70,628.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VTGN WACC - Weighted Average Cost of Capital

The WACC of VistaGen Therapeutics Inc (VTGN) is 5.8%.

The Cost of Equity of VistaGen Therapeutics Inc (VTGN) is 7.85%.
The Cost of Debt of VistaGen Therapeutics Inc (VTGN) is 5.00%.

Range Selected
Cost of equity 6.80% - 8.90% 7.85%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.2% - 6.3% 5.8%
WACC

VTGN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.64 0.73
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.80% 8.90%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.2% 6.3%
Selected WACC 5.8%